UCB, Inc. v. Cipla Limited
| UCB, INC., UCB BIOPHARMA SRL, HANANJA EHF and UNIVERSITY OF ICELAND |
| CIPLA LIMITED and CIPLA USA INC. |
| 26-1992 |
| July 1, 2026 |
| U.S. Court of Appeals, Federal Circuit |
| Patent - (ANDA) (Fed. Qst.) |
Docket Report
RSS Track this Docket
This docket was last retrieved on July 1, 2026. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 1 Appeal docketed. Received: 06/26/2026. [1177000] Entry of Appearance is due on 07/15/2026. Certificate of Interest is due on 07/15/2026. Docketing Statement is due on 07/15/2026. Appellant's brief is due on 08/31/2026. [IMH] [Entered: 07/01/2026 10:54 AM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
